![Shawn O'Brien](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Shawn O'Brien
Amministratore Delegato presso
SFA Therapeutics, Inc.
Patrimonio netto: 572 227 $ in data 31/08/2026
Profilo
Shawn Patrick O'Brien was the founder of AltheRx, Inc., founded in 2010, where the titles held included President, Chief Executive Officer & Director from 2010 to 2013.
Current jobs include Chairman & Chief Executive Officer at SFA Therapeutics, Inc. starting in 2026, and Chairman at Alto Pharmaceuticals Ltd. Former jobs include President, Chief Executive Officer & Director at Solstice Neurosciences, Inc. from 2004 to 2007; President, Chief Executive Officer & Director at Profectus BioSciences, Inc. from 2008 to 2010; Chief Executive Officer, Director & MD at Mayne Pharma Group Ltd. from 2022 to 2026; Chief Executive Officer & Director at Genomind, Inc.; Director at Crozer-Keystone Health System from 2008 to 2016; Director at Melanovus Oncology, Inc. from 2013 to 2014; Director at Cyrano LLC; Principal at The Upjohn Co.; President at Cipher Pharmaceuticals, Inc. from 2016 to 2017; and Vice President-Commercial Operations at AstraZeneca Pharmaceuticals LP in 2004.
Education includes undergraduate studies at the University of Western Ontario.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 20/02/2026 | 257.573 ( 0,31% ) | 572 227 $ | 31/08/2026 |
Posizioni attive di Shawn O'Brien
| Società | Posizione | Inizio |
|---|---|---|
Alto Pharmaceuticals Ltd.
 Alto Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies pharmaceutical products | Presidente | - |
SFA Therapeutics, Inc.
 SFA Therapeutics, Inc. Packaged SoftwareTechnology Services Operates as a platform that provides treatment services for chronic diseases | Amministratore Delegato | 19/08/2026 |
Precedenti posizioni note di Shawn O'Brien
| Società | Posizione | Fine |
|---|---|---|
| MAYNE PHARMA GROUP LIMITED | Amministratore Delegato | 20/02/2026 |
| CIPHER PHARMACEUTICALS INC. | Amministratore Delegato | 11/11/2016 |
Crozer-Keystone Health System
 Crozer-Keystone Health System Medical/Nursing ServicesHealth Services Provides healthcare services | Direttore/Membro del Consiglio | 01/06/2016 |
Melanovus Oncology, Inc.
 Melanovus Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Provides laboratory testing services | Direttore/Membro del Consiglio | 01/12/2014 |
Altherx, Inc.
 Altherx, Inc. Miscellaneous Commercial ServicesCommercial Services Offers clinical development for overactive bladder and irritable bowel syndrome | Fondatore | 01/02/2013 |
Formazione di Shawn O'Brien
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
49
Relazioni di 1° grado
14
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 14 |
|---|---|
The Upjohn Co.
 The Upjohn Co. Pharmaceuticals: MajorHealth Technology Manufacturer of pharmaceuticals | Health Technology |
Cipher Pharmaceuticals, Inc.
 Cipher Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Provides laboratory testing and medical imaging services | Health Technology |
Solstice Neurosciences, Inc.
 Solstice Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, sells and markets biopharmaceutical products | Health Technology |
University of Western Ontario
 University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Crozer-Keystone Health System
Crozer-Keystone Health System Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Profectus BioSciences, Inc.
 Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Designs and develops preventive and therapeutic vaccines | Health Technology |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Health Technology |
Mayne Pharma Group Ltd.
 Mayne Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company, which develops and manufactures proprietary and generic products | Health Technology |
Altherx, Inc.
Altherx, Inc. Miscellaneous Commercial ServicesCommercial Services Offers clinical development for overactive bladder and irritable bowel syndrome | Commercial Services |
Genomind, Inc.
 Genomind, Inc. Medical/Nursing ServicesHealth Services Provides molecular diagnostics services | Health Services |
Melanovus Oncology, Inc.
Melanovus Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Provides laboratory testing services | Commercial Services |
Alto Pharmaceuticals Ltd.
Alto Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies pharmaceutical products | Health Technology |
SFA Therapeutics, Inc.
SFA Therapeutics, Inc. Packaged SoftwareTechnology Services Operates as a platform that provides treatment services for chronic diseases | Technology Services |
Cyrano LLC |
